US 8785491
Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
granted A61KA61K31/343A61K41/0057
Quick answer
US patent 8785491 (Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/343, A61K41/0057, A61K45/06, A61P